AMPLITUDE: A Phase 2/3 Adaptive Trial of Inaxaplin in APOL1-Mediated Kidney Disease

Authors: Glenn M. Chertow, George Manos, Ogo I. Egbuna

Published: 2024-10-28

DOI: 10.1681/asn.20241x7qn0bv

Keywords: No keywords found.

Abstract:
No abstract found.

Source: